Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice

 

Ittner, A., Chua SW., Bertz, J. et al.

Science 2016, vol:354(6314), 904-908 doi: 10.1126/science.aah6205

Abstract

Amyloid-β (Aβ) toxicity in Alzheimer’s disease (AD) is considered to be mediated by phosphorylated tau protein. In contrast, we found that, at least in early disease, site-specific phosphorylation of tau inhibited Aβ toxicity. This specific tau phosphorylation was mediated by the neuronal p38 mitogen-activated protein kinase p38γ and interfered with postsynaptic excitotoxic signaling complexes engaged by Aβ. Accordingly, depletion of p38γ exacerbated neuronal circuit aberrations, cognitive deficits, and premature lethality in a mouse model of AD, whereas increasing the activity of p38γ abolished these deficits. Furthermore, mimicking site-specific tau phosphorylation alleviated Aβ-induced neuronal death and offered protection from excitotoxicity. Our work provides insights into postsynaptic processes in AD pathogenesis and challenges a purely pathogenic role of tau phosphorylation in neuronal toxicity.

View Publication

Topics: Neurodegenerative diseases, Monolith – MicroScale Thermophoresis, MST,  Publications

 

 

Previous Article
These 7 key proteins may hold the key to effective therapies for neurodegenerative diseases
These 7 key proteins may hold the key to effective therapies for neurodegenerative diseases

While the processes involved in the genesis and accumulation of misfolded proteins were initially thought t...

Up next
3 biggest challenges in neurodegenerative disease research and why you should focus on them
3 biggest challenges in neurodegenerative disease research and why you should focus on them

Neurodegenerative diseases (ND) are very complex disorders. Not only is each one different, displaying uniq...

Characterize the molecular mechanisms of neurodegenerative diseases

Learn how